Pfizer to send COVID-19 treatment drugs worth $70 mn to India
The firm will be sending drugs that have been identified as part of India s COVID-19 treatment protocol, according to Pfizer s Chairman and CEO Albert Bourla.
BusinessToday.In | May 3, 2021 | Updated 14:31 IST
Bourla shared a mail that had been sent to Pfizer s employees in India
American pharmaceutical giant Pfizer announced on Monday that it is sending medicines worth $70 million to India. The firm will be sending drugs that have been identified as part of India s COVID-19 treatment protocol, according to Pfizer s Chairman and CEO Albert Bourla. The medicines will come from Pfizer s distribution centres in the US, Europe and Asia.
URL copied
Pfizer study suggests vaccine works against coronavirus variant
New research suggests that Pfizerâs COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants are causing global concern. They both share a common mutation called N501Y, a slight alteration on one spot of the spike protein that coats the virus. That change is believed to be the reason they can spread so easily.
Most of the vaccines being rolled out around the world train the body to recognize that spike protein and fight it. Pfizer teamed with researchers from the University of Texas Medical Branch in Galveston for laboratory tests to see if the mutation affected its vaccineâs ability to do so.